Hepatitis C Combination Therapy - HIV-HCV Coinfected Patients Receive Treatment for Chronic Hepatitis C Less Frequently Than HCV Monoinfected

HIV-HCV Coinfected Patients Receive Treatment for Chronic Hepatitis C Less Frequently Than HCV Monoinfected
HIV and Hepatitis.com - By Marina Nunez, MD "End-stage liver disease has become a leading cause of morbidity and mortality in HIV-infected patients since the introduction of HAART.

MIGENIX initiates enrolment in Phase IIb HCV study of celgosivir+Pegetron
InPharm.com - Celgosivir is a first-in-class, orally-administered, alpha glucosidase 1 inhibitor in development for the treatment of chronic hepatitis C (HCV) infections. Results of the study are anticipated in mid-2006.

Valeant Shares Advance on Review of Drug
AP via Newsday - is a treatment for adult patients suffering from chronic hepatitis C viral infections with compensated liver disease

Early treatment of hepatitis C effective in HIV-positive patients
Aidsmap - Liver diseases including hepatitis C are an important cause of disease in HIV-positive patients. Although the treatment of chronic hepatitis C infection in HIV-positive patients has been assessed in a number of large